LBF20207PG26: Difference between revisions
m (LBF20307PG10 moved to LBF20207PG26) |
No edit summary |
||
Line 5: | Line 5: | ||
|LipidMaps=LMFA03010026 | |LipidMaps=LMFA03010026 | ||
|SysName=7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3-oxo-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid | |SysName=7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3-oxo-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid | ||
|Common Name=&&15-KETOPROSTAGLANDIN | |Common Name=&&15-KETOPROSTAGLANDIN F_2alpha&& | ||
}} | }} |
Revision as of 07:29, 19 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1511 |
LipidMaps | LMFA03010026 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG26 |
15-KETOPROSTAGLANDIN F_2α | |
---|---|
Structural Information | |
7- [ 3 (R) ,5 (S) -Dihydroxy-2 (R) - (3-oxo-1 (E) -octenyl) cyclopentan-1 (R) -yl ] -5 (Z) -heptenoic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CCC(=O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|